Nor Syafinaz Yaakob

Dr. Nor Syafinaz Yaakob

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Helen IrvingHelen Irving
Helen Irving
Ilona TurekIlona Turek
Ilona Turek
CKChristine Kettle
Christine Kettle
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob
5-hydroxytryptamine type 3 (5-HT3) receptors are ligand gated ion channels, which clearly distinguish their mode of action from the other G-protein coupled 5-HT or serotonin receptors. 5-HT3 receptors are well established targets for emesis and gastrointestinal mobility and are used as adjunct targets in treating schizophrenia. However, the distribution of these receptors is wider than the nervous system and there is potential that these additional sites can be targeted to modulate inflammatory and/or metabolic conditions. Recent progress in structural biology and pharmacology of 5-HT3 receptors have provided profound insights into mechanisms of their action. These advances, combined with insights into clinical relevance of mutations in genes encoding 5-HT3 subunits and increasing understanding of their implications in patient’s predisposition to diseases and response to the treatment, open new avenues for personalized precision medicine. In this review, we recap on the current status of 5-HT3 receptor-based therapies using a biochemical and physiological perspective. We assess the potential for targeting 5-HT3 receptors in conditions involving metabolic or inflammatory disorders based on recent findings, underscoring the challenges and limitations of this approach.

1 February 2011 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob
DMD. T. Malone
D. T. Malone
BEBetty Exintaris
Betty Exintaris
Helen IrvingHelen Irving
Helen Irving
The serotonin 3 (5-HT3) receptor is a ligand gated ion channel unlike the other 5-HT receptors which are G protein coupled receptors. The functional 5-HT3 receptor forms a pentamer of five symmetrically arranged subunits surrounding a central pore. The 5-HT3A subunit was first identified at a molecular level and can form functional homomers or heteromers with the 5-HT3B subunit. Recently, three new 5-HT3 subunits have been discovered and these can also form functional heteromers with the 5-HT3A subunit. In addition, splice variants of the 5-HT3 subunits have also been reported. These findings have markedly increased the complexity of the 5-HT3 receptor and may form part of the explanation of unresolved differences between studies investigating 5-HT3 receptor function in cell lines compared with native tissues. In this review we discuss the properties of the different subunits and their distribution to determine if they contribute to functional changes in the 5-HT3 receptor. Several recent pharmacogenomic studies have revealed single nucleotide polymorphisms (SNPs) and other variations in the different 5-HT3 receptor subunits that are associated with various clinical conditions. We discuss the implications of these findings with respect to drug design and tailored pharmacogenomic therapies.

1 April 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MZMuhammad Harith Zulkifli
Muhammad Harith Zulkifli
PVPraveena Viswenaden
Praveena Viswenaden
MJMalina Jasamai
Malina Jasamai
NANorazrina Azmi
Norazrina Azmi
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob
5-HT3R antagonists such as ondansetron, granisetron and tropisetron have been clinically used to treat nausea and vomiting in chemotherapy patients. However, current study and research revealed novel potentials of these ligands in other diseases like inflammation, Alzheimer's, and drug abuse. Towards utilising these drugs as anti-smoking agents to treat nicotine dependence problem, there are conflicting reports regarding the potential of these ligands in modulating the effects of nicotine in both human and animal behavioural studies. This is complicated by the heterogeneity of 5-HT3R itself, cross regulation between nicotinic acetylcholinergic receptor (nAChR) and distinct pharmacological profiles of 5-HT3R antagonists. This review gathered existing studies conducted investigating the potential of "-setron" class of 5-HT3R antagonists in modulating nicotine effects. We proposed that the mechanism where 5-HT3R antagonists mediate the effects of nicotine could be attributed by both direct at 5-HT3R and indirect mechanism in nicotine addiction downstream regulation. The indirect mechanism mediated by the 5-HT3R antagonist could be through α7 nAChR, 5-HT1B receptor (5-HT1BR), 5-HT1C receptor (5-HT1CR), calcineurin activity, p38 MAPK level, PPAR-γ and NF-κβ. Our review suggested that future studies should focus on newer 5-HT3R antagonist with superior pharmacological profile or the one with multitarget action rather than high selectivity at single receptor.

5 January 2026 in Pharmacy Education
Verified
Journal Article
Closed access
PDF file
ECEng Wee Chua
Eng Wee Chua
MZMohd Hanif Zulfakar
Mohd Hanif Zulfakar
AAAdliah Mhd Ali
Adliah Mhd Ali
HKHaliza Katas
Haliza Katas
JJJuriyati Jalil
Juriyati Jalil
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob
Background: Entrepreneurship is an increasingly indispensable element of higher education due to its potential application in providing sustainable solutions to various social issues. Delivering entrepreneurship education to university students with diverse backgrounds and not just business students require innovative and integrative approaches. Given the lack of social elements in the current entrepreneurship education for pharmacy students, introducing a social entrepreneurship module might be beneficial. The objective of the present study is to develop and evaluate a new module for teaching social entrepreneurial skills to pharmacy students. Methods: This report describes the conception and implementation of an experiential learning module as a student-led community project within the Bachelor of Pharmacy programme at the Faculty of Pharmacy, Kuala Lumpur Campus, Universiti Kebangsaan Malaysia. The effectiveness of the one-semester module was analysed via students’ reflection essays on their experiences of participating in the project, and thematic data was coded and summarised. Results: Most students reported gaining organisational and interpersonal skills such as effective communication and teamwork. Notably, some students also developed entrepreneurial skills and social awareness. Conclusion: The outcomes of this study showed that the entrepreneurship module was effective and well received by pharmacy students and may be replicated for effective teaching of entrepreneurship at other universities.

11 April 2025 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
RSRaajeswari Satiamurthy
Raajeswari Satiamurthy
NSNoraida Mohamed Shah
Noraida Mohamed Shah
NMNur Fa’IZah Ab Muin
Nur Fa’IZah Ab Muin
NANorazrina Azmi
Norazrina Azmi
CIChe Aishah Nazariah Ismail
Che Aishah Nazariah Ismail
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob

9 April 2025 in OBM Neurobiology
Verified
Journal Article
Open access
PDF file
CIChe Aishah Nazariah Ismail
Che Aishah Nazariah Ismail
NSNazlahshaniza Shafin
Nazlahshaniza Shafin
Khairunnuur Fairuz AzmanKhairunnuur Fairuz Azman
Khairunnuur Fairuz Azman
ILIDRIS LONG
IDRIS LONG
NYNor Syafinaz Yaakob
Nor Syafinaz Yaakob
Chronic pain is a significant and global healthcare issue that hugely implies the quality of life and productivity of the affected individuals. It is challenging to treat and thus necessitates a deeper understanding of its underlying pathomechanisms to develop targeted interventions. Serotonin is one of the essential neurotransmitters involved in the propagation of pain signals through both ascending and descending pathways, acting via various receptor subtypes, including the 5-hydroxytryptamine receptor-6 (5-HT6R). Recent studies have shed light on the involvement of 5-HT6R in the pathophysiology of chronic pain. This review aimed to uncover the emerging roles of 5-HT6R in chronic pain research by focusing on its functions in pain modulation, neuronal excitability, and pain processing. Although 5-HT6R has been recently discovered, previous studies have revealed its therapeutic effects in modulating chronic pain. Understanding the precise mechanism underlying the 5-HT6R may offer new avenues for future strategies of chronic pain management and indirectly improve the individual’s quality of life. However, further research is warranted to elucidate the intricate interplay between 5-HT6R and other pain modulatory pathways, paving the way for more effective and tailored therapeutic strategies for chronic pain.